← Evidence map

ArticleVirus evolution2024

Combined use of pritelivir with acyclovir or foscarnet suppresses evolution of HSV-1 drug resistance.

Hanna Helena Schalkwijk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39717706